VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
New York Medical College
St. Jude Children's Research Hospital
Children's Hospital of Philadelphia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Milton S. Hershey Medical Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Baylor College of Medicine
Iovance Biotherapeutics, Inc.
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Cellectar Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
University of Florida
Baylor College of Medicine
Endeavor Biomedicines, Inc.
St. Jude Children's Research Hospital
Tianjin Medical University Cancer Institute and Hospital
Emory University
Eli Lilly and Company
Dana-Farber Cancer Institute
Children's Oncology Group
Seattle Children's Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Children's National Research Institute
Baylor College of Medicine
Baylor College of Medicine
Fudan University
St. Jude Children's Research Hospital
Massachusetts General Hospital
St. Jude Children's Research Hospital
ITM Solucin GmbH
University of Rochester
National Cancer Institute (NCI)
National Cancer Institute (NCI)